IT8367922A0 - Derivato del carbostirile procedimento per la sua preparazione e composizione farmaceutica contenente tale derivato - Google Patents
Derivato del carbostirile procedimento per la sua preparazione e composizione farmaceutica contenente tale derivatoInfo
- Publication number
- IT8367922A0 IT8367922A0 IT8367922A IT6792283A IT8367922A0 IT 8367922 A0 IT8367922 A0 IT 8367922A0 IT 8367922 A IT8367922 A IT 8367922A IT 6792283 A IT6792283 A IT 6792283A IT 8367922 A0 IT8367922 A0 IT 8367922A0
- Authority
- IT
- Italy
- Prior art keywords
- derivative
- preparation
- pharmaceutical composition
- composition containing
- procedure
- Prior art date
Links
- MJXYFLJHTUSJGU-UHFFFAOYSA-N 7-amino-4-methyl-1h-quinolin-2-one Chemical class NC1=CC=C2C(C)=CC(=O)NC2=C1 MJXYFLJHTUSJGU-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15409082A JPS5962585A (ja) | 1982-09-03 | 1982-09-03 | カルボスチリル誘導体 |
| JP57213167A JPS59104378A (ja) | 1982-12-03 | 1982-12-03 | カルボスチリル誘導体 |
| JP58114679A JPS606685A (ja) | 1983-06-24 | 1983-06-24 | カルボスチリル誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8367922A0 true IT8367922A0 (it) | 1983-09-05 |
| IT1193145B IT1193145B (it) | 1988-06-02 |
Family
ID=27312797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT67922/83A IT1193145B (it) | 1982-09-03 | 1983-09-05 | Derivato del carbostirile procedimento per la sua preparazione e composizione farmaceutica contenente tale derivato |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4564619A (it) |
| KR (1) | KR910000181B1 (it) |
| CA (1) | CA1252469A (it) |
| CH (1) | CH655110A5 (it) |
| DE (1) | DE3331808A1 (it) |
| ES (4) | ES525346A0 (it) |
| FR (1) | FR2532648B1 (it) |
| GB (1) | GB2127402B (it) |
| IT (1) | IT1193145B (it) |
| NL (1) | NL8303066A (it) |
| SE (1) | SE455503B (it) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ212209A (en) * | 1984-05-29 | 1988-08-30 | Pfizer | Quinolone derivatives and pharmaceutical compositions |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| KR940000785B1 (ko) * | 1986-04-02 | 1994-01-31 | 오오쓰까세이야꾸 가부시끼가이샤 | 카르보스티릴 유도체 및 그의 염의 제조 방법 |
| DK167187A (da) * | 1986-04-02 | 1987-10-03 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse |
| KR100305515B1 (ko) * | 1999-02-04 | 2001-09-24 | 이순금 | 메주의 제조방법 |
| NL1012886C1 (nl) | 1999-08-23 | 2001-02-26 | Rephartox | 1,4-Dihydropyridine-5-carbonzuuresterderivaten en werkwijze voor de bereiding ervan. |
| KR100422242B1 (ko) * | 2001-07-20 | 2004-03-12 | 농업회사법인(주)맛가마식품 | 중공봉형상 메주와 이를 이용한 간장 및 된장 제조방법과제조용 장독 |
| US20070066619A1 (en) * | 2002-10-07 | 2007-03-22 | Artesian Therapeutics, Inc. | Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| PL376405A1 (en) * | 2002-10-07 | 2005-12-27 | Artesian Therapeutics, Inc. | Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| NL1028564C2 (nl) * | 2005-03-17 | 2006-09-20 | Rademaker Holding B V | Toepassing van een coumarine-groep omvattende derivaten voor de bereiding van een antiviraal middel, coumarine-group omvattende derivaten, een werkwijze voor de bereiding daarvan, en farmaceutische preparaten die deze bevatten. |
| US7678363B2 (en) | 2005-08-26 | 2010-03-16 | Braincells Inc | Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| EP1940389A2 (en) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| EP1991212A1 (en) * | 2006-03-08 | 2008-11-19 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| EP2021000A2 (en) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| MX2008014320A (es) * | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| EP2068872A1 (en) * | 2006-09-08 | 2009-06-17 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| EP2066355A2 (en) * | 2006-09-19 | 2009-06-10 | Braincells, Inc. | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| EP2804603A1 (en) | 2012-01-10 | 2014-11-26 | President and Fellows of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3971797A (en) * | 1973-06-15 | 1976-07-27 | Merck & Co., Inc. | S,S'-bis(pyridylmethyl)-carbonodithioates |
| DE2508181A1 (de) * | 1975-02-26 | 1976-09-09 | Bayer Ag | 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4081447A (en) * | 1975-04-09 | 1978-03-28 | Abbott Laboratories | 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof |
| DE2659665A1 (de) * | 1976-12-30 | 1978-07-13 | Nattermann A & Cie | Neue 1,4-dihydropyridin-derivate |
| JPS5387368A (en) * | 1977-01-12 | 1978-08-01 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
| JPS5390270A (en) * | 1977-01-14 | 1978-08-08 | Otsuka Pharmaceut Co Ltd | Carbostryl derivs. |
| IE46852B1 (en) * | 1977-06-10 | 1983-10-05 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives |
| DE2805404A1 (de) * | 1978-02-09 | 1979-08-16 | Merck Patent Gmbh | 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung |
| IT1097538B (it) * | 1978-07-17 | 1985-08-31 | Medea Res Srl | Processo per la preparazione del 2,6-dimetil-4-3(3-nitrofenil)-3-metossicarbonil-1,4-didropiridin-5-carbossilati di 2(n-benzil-n-metilammino) |
| CA1117117A (en) * | 1978-10-10 | 1982-01-26 | Fujisawa Pharmaceutical Co., Ltd. | 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same |
| DE3034237A1 (de) * | 1979-09-18 | 1981-04-16 | Otsuka Pharmaceutical Co. Ltd., Tokyo | Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel |
| PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
| JPS5777676A (en) * | 1980-10-31 | 1982-05-15 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
| JPS57200386A (en) * | 1981-06-04 | 1982-12-08 | Yoshitomi Pharmaceut Ind Ltd | Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts |
-
1983
- 1983-09-01 CH CH4807/83A patent/CH655110A5/de not_active IP Right Cessation
- 1983-09-02 ES ES525346A patent/ES525346A0/es active Granted
- 1983-09-02 CA CA000435962A patent/CA1252469A/en not_active Expired
- 1983-09-02 FR FR8314115A patent/FR2532648B1/fr not_active Expired
- 1983-09-02 US US06/528,887 patent/US4564619A/en not_active Expired - Fee Related
- 1983-09-02 KR KR1019830004144A patent/KR910000181B1/ko not_active IP Right Cessation
- 1983-09-02 GB GB08323542A patent/GB2127402B/en not_active Expired
- 1983-09-02 NL NL8303066A patent/NL8303066A/nl not_active Application Discontinuation
- 1983-09-02 DE DE19833331808 patent/DE3331808A1/de not_active Withdrawn
- 1983-09-02 SE SE8304737A patent/SE455503B/sv not_active IP Right Cessation
- 1983-09-05 IT IT67922/83A patent/IT1193145B/it active
-
1984
- 1984-05-16 ES ES532538A patent/ES8506697A1/es not_active Expired
- 1984-05-16 ES ES532536A patent/ES532536A0/es active Granted
- 1984-05-16 ES ES532537A patent/ES8601187A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB2127402B (en) | 1987-01-14 |
| GB8323542D0 (en) | 1983-10-05 |
| ES8505998A1 (es) | 1985-06-16 |
| SE455503B (sv) | 1988-07-18 |
| CA1252469A (en) | 1989-04-11 |
| CH655110A5 (de) | 1986-03-27 |
| ES532538A0 (es) | 1985-07-16 |
| ES532537A0 (es) | 1985-10-16 |
| ES8506697A1 (es) | 1985-07-16 |
| SE8304737L (sv) | 1984-03-04 |
| US4564619A (en) | 1986-01-14 |
| ES8502686A1 (es) | 1985-01-16 |
| KR910000181B1 (ko) | 1991-01-21 |
| NL8303066A (nl) | 1984-04-02 |
| ES532536A0 (es) | 1985-06-16 |
| ES8601187A1 (es) | 1985-10-16 |
| SE8304737D0 (sv) | 1983-09-02 |
| DE3331808A1 (de) | 1984-03-08 |
| ES525346A0 (es) | 1985-01-16 |
| GB2127402A (en) | 1984-04-11 |
| KR850000402A (ko) | 1985-02-27 |
| FR2532648B1 (fr) | 1989-07-21 |
| FR2532648A1 (fr) | 1984-03-09 |
| IT1193145B (it) | 1988-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8367922A0 (it) | Derivato del carbostirile procedimento per la sua preparazione e composizione farmaceutica contenente tale derivato | |
| IT8167311A0 (it) | Derivati carbostirilici procedimento per la loro preparazione e composizioni farmaceutiche contenenti tali derivati | |
| IT8023228A0 (it) | Composizione farmaceutica a cessione prolungata contenente un medicamento solido e procedimento per la sua preparazione. | |
| IT8168566A0 (it) | Complesso antibiotico procedimento per la sua preparazione composizione farmaceutica contenente tale complesso e microorganismo per l attuazione di tale procedimento | |
| IT8922164A0 (it) | Composizione farmaceutica e procedimento per la sua preparazione | |
| IT1125469B (it) | Composto 2-metil-diidropirindinico,procedimenti per la sua preparazione e composizione farmaceutica che lo comprende | |
| IT8147821A0 (it) | Di sostanze medicamentose dispositivo per la somministrazione | |
| IT1209896B (it) | Antibiotico bmg162-af2 procedimento per la sua produzione e medicinale antitumorale contenente il suddetto antibiotico come ingrediente attivo | |
| IT1119922B (it) | Sostanza anti tumorale e procedimento per la sua preparazione | |
| IT1171361B (it) | Amminociclopentanon-ammidi e procedimento per la loro preparazione e formulazione farmaceutica | |
| IT1141591B (it) | Prodotto disinfestante e procedimento per la sua preparazione | |
| IT1099569B (it) | Sostanza antitumorale e procedimento per la sua preparazione | |
| IT1188917B (it) | Composto antibatterico antitumorale e procedimento per la sua preparazione | |
| IT1134458B (it) | Derivato della n-acetil-cisteina ad attivita' terapeutica,procedimento per la sua preparazione e relative composizioni farmaceutiche | |
| IT1156515B (it) | Composto terapeutico antiipertensivo procedimento per la sua preparazione e composizioni farmaceutiche contenenti tale composto | |
| MX6962E (es) | Procedimiento para la preparacion de una composicion farmaceutica antidiarreica | |
| IT1143199B (it) | Composizione farmaceutica antitumorale e procedimento per la sua preparazione | |
| IT1145371B (it) | Alcossi-acil carnitine procedimento per la loro preparazione e composizioni farmaceutiche che le contengono | |
| IT1133086B (it) | Preparato medicinale per trattare carcinomi e procedimento per la sua produzione | |
| IT1133051B (it) | Supposta farmaceutica e procedimento per la sua preparazione | |
| IT8047792A0 (it) | Composizione farmaceutica con atti vita' antiaterosclerotica e procedimento per la sua preparazione | |
| DK471783A (da) | Farmaceutisk praeparat og fremgangsmaade til fremstilling deraf | |
| IT1172268B (it) | Piperidinoguanidine sostituite,procedimento per la loro preparazione e composizioni farmaceutiche che le contengono | |
| FI830245A0 (fi) | Foerbaettringar beroerande via naesan intagbara farmaceutiska kompositioner | |
| IT8050159A0 (it) | Derivato del chinazolinone la sua preparazione e composizioni farmaceutiche contenenti questo prodotto |